Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
1,008
-
Total 13F shares, excl. options
-
90,013,397
-
Shares change
-
+1,235,153
-
Total reported value, excl. options
-
$54,432,928,676
-
Value change
-
+$779,583,867
-
Put/Call ratio
-
130%
-
Number of buys
-
529
-
Number of sells
-
396
-
Price
-
$605.18
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2021
As of 30 Sep 2021 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,008 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 90,013,397 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, LOOMIS SAYLES & CO L P, GEODE CAPITAL MANAGEMENT, LLC, and PUTNAM INVESTMENTS LLC.
This table shows 1,010 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.